Utility of PSMA-PET imaging.
作者信息
Ahmadzadehfar Hojjat, Biersack Hans Jürgen
出版信息
Dtsch Arztebl Int. 2021 Sep 6;118I processed the file.I'm waiting for feedback tomorrow(35-36):603. doi: 10.3238/arztebl.m2021.0234.
Abstract
摘要
相似文献
1
Utility of PSMA-PET imaging.
Dtsch Arztebl Int. 2021 Sep 6;118I processed the file.I'm waiting for feedback tomorrow(35-36):603. doi: 10.3238/arztebl.m2021.0234.
2
Prostate Cancer: Prostate-specific Membrane Antigen Positron-emission Tomography/Computed Tomography or Positron-emission Tomography/Magnetic Resonance Imaging for Staging.
Top Magn Reson Imaging. 2020 Feb;29(1):59-66. doi: 10.1097/RMR.0000000000000229.
3
The Impact of 68Ga-PSMA PET/CT and PET/MRI on the Management of Prostate Cancer.
Urology. 2019 Aug;130:1-12. doi: 10.1016/j.urology.2019.04.004. Epub 2019 Apr 12.
4
Utility of Ga prostate specific membrane antigen - positron emission tomography in diagnosis and response assessment of recurrent renal cell carcinoma.
J Med Imaging Radiat Oncol. 2017 Jun;61(3):372-378. doi: 10.1111/1754-9485.12590. Epub 2017 Jan 24.
5
The Role of Radiolabeled Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography for the Evaluation of Renal Cancer.
Eur Urol Focus. 2020 Jan 15;6(1):146-150. doi: 10.1016/j.euf.2018.08.004. Epub 2018 Aug 16.
6
Tumour-capsule interface measured on 18F-DCFPyL PSMA positron emission tomography/CT imaging comparable to multi-parametric MRI in predicting extra-prostatic extension of prostate cancer at initial staging.
J Med Imaging Radiat Oncol. 2020 Dec;64(6):829-838. doi: 10.1111/1754-9485.13084. Epub 2020 Jul 27.
7
Ga-Labeled Prostate-specific Membrane Antigen Ligand Positron Emission Tomography/Computed Tomography for Prostate Cancer: A Systematic Review and Meta-analysis.
Eur Urol Focus. 2018 Sep;4(5):686-693. doi: 10.1016/j.euf.2016.11.002. Epub 2016 Nov 15.
8
Whole-Body Integrated [Ga]PSMA-11-PET/MR Imaging in Patients with Recurrent Prostate Cancer: Comparison with Whole-Body PET/CT as the Standard of Reference.
Mol Imaging Biol. 2020 Jun;22(3):788-796. doi: 10.1007/s11307-019-01424-4.
9
Differentiating benign and malignant pancreatic masses: Ga-68 PSMA PET/CT as a new diagnostic avenue.
Eur Radiol. 2021 Apr;31(4):2199-2208. doi: 10.1007/s00330-020-07318-2. Epub 2020 Oct 1.
10
Regional Lymph Node Metastasis on Prostate Specific Membrane Antigen Positron Emission Tomography Correlates with Decreased Biochemical Recurrence-Free and Therapy-Free Survival after Radical Prostatectomy: A Retrospective Single-Center Single-Arm Observational Study.
J Urol. 2021 Jun;205(6):1663-1670. doi: 10.1097/JU.0000000000001596. Epub 2021 Feb 4.
本文引用的文献
1
Options for Curative Treatment of Localized Prostate Cancer.
Dtsch Arztebl Int. 2021 Apr 2;118(Forthcoming):228-36. doi: 10.3238/arztebl.m2021.0026.
2
Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study.
Lancet. 2020 Apr 11;395(10231):1208-1216. doi: 10.1016/S0140-6736(20)30314-7. Epub 2020 Mar 22.
3
PSMA-Based Theranostics: A Step-by-Step Practical Approach to Diagnosis and Therapy for mCRPC Patients.
Semin Nucl Med. 2020 Jan;50(1):98-109. doi: 10.1053/j.semnuclmed.2019.07.003. Epub 2019 Aug 21.
Zotero 插件